ArticleJournal for immunotherapy of cancer2022

Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells.

Celia Martín-Otal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.